1. Home
  2. ACET vs OSS Comparison

ACET vs OSS Comparison

Compare ACET & OSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACET
  • OSS
  • Stock Information
  • Founded
  • ACET 1947
  • OSS 1998
  • Country
  • ACET United States
  • OSS United States
  • Employees
  • ACET N/A
  • OSS N/A
  • Industry
  • ACET Biotechnology: Pharmaceutical Preparations
  • OSS Computer Manufacturing
  • Sector
  • ACET Health Care
  • OSS Technology
  • Exchange
  • ACET Nasdaq
  • OSS Nasdaq
  • Market Cap
  • ACET 75.6M
  • OSS 79.8M
  • IPO Year
  • ACET N/A
  • OSS 2018
  • Fundamental
  • Price
  • ACET $0.91
  • OSS $4.09
  • Analyst Decision
  • ACET Strong Buy
  • OSS Strong Buy
  • Analyst Count
  • ACET 4
  • OSS 2
  • Target Price
  • ACET $5.67
  • OSS $5.25
  • AVG Volume (30 Days)
  • ACET 513.3K
  • OSS 208.6K
  • Earning Date
  • ACET 11-06-2024
  • OSS 11-06-2024
  • Dividend Yield
  • ACET N/A
  • OSS N/A
  • EPS Growth
  • ACET N/A
  • OSS N/A
  • EPS
  • ACET N/A
  • OSS N/A
  • Revenue
  • ACET N/A
  • OSS $52,709,421.00
  • Revenue This Year
  • ACET N/A
  • OSS N/A
  • Revenue Next Year
  • ACET N/A
  • OSS $9.40
  • P/E Ratio
  • ACET N/A
  • OSS N/A
  • Revenue Growth
  • ACET N/A
  • OSS N/A
  • 52 Week Low
  • ACET $0.81
  • OSS $1.79
  • 52 Week High
  • ACET $3.62
  • OSS $4.58
  • Technical
  • Relative Strength Index (RSI)
  • ACET 43.86
  • OSS 69.16
  • Support Level
  • ACET $0.85
  • OSS $3.05
  • Resistance Level
  • ACET $0.94
  • OSS $3.80
  • Average True Range (ATR)
  • ACET 0.08
  • OSS 0.34
  • MACD
  • ACET 0.00
  • OSS 0.02
  • Stochastic Oscillator
  • ACET 22.16
  • OSS 90.58

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bresssner segment.

Share on Social Networks: